Indeed, in the tumor microenvironment α-MSH via down-regulation of cell adhesion molecules or MHC class I expression might reduce the migratory capacity of tumor-specific T cells and the interaction between melanoma cells and cytotoxic T cells [46]–[50]. The gene discussed is STAMBP; the disease is neoplasm.